M/Z: 715.4348
Hit 2 annotations: PA(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z))_[M+H]+
; Cyclopassifloside VII_[M+H]+
- Confirmed: 这个参考离子已经通过手动审计得到确认和验证。
- Reliable: 这个参考离子可能在特定的解剖组织环境中高度保守。
- Unreliable: 这个参考离子具有较高的排名价值,但缺乏可重复性。
- Unavailable: 由于排名价值低且缺乏可重复性,这个参考离子不应用于注释。
Found 3 Reference Ions Near m/z 715.4348
NovoCell ID | m/z | Mass Window | Metabolite | Ranking | Anatomy Context |
---|---|---|---|---|---|
MSI_000004179 Unreliable | 715.4348 | 715.4348 ~ 715.4348 MzDiff: none |
PA(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (BioDeep_00000107400) Formula: C41H63O8P (714.426) |
0.93 (100%) | Homo sapiens [UBERON:0002107] liver |
MSI_000026219 Unreliable | 715.4299 | 715.4299 ~ 715.4299 MzDiff: none |
Cyclopassifloside VII (BioDeep_00000025920) Formula: C37H62O13 (714.419) |
1.81 (100%) | Mus musculus [UBERON:0000913] interstitial fluid |
MSI_000026725 Unreliable | 715.4429 | 715.4429 ~ 715.4429 MzDiff: none |
PA(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (BioDeep_00000107400) Formula: C41H63O8P (714.426) |
1.79 (100%) | Mus musculus [UBERON:0002048] lung |
Found 2 Sample Hits
Metabolite | Species | Sample | |
---|---|---|---|
PA(18:4(6Z,9Z,12Z,15Z)/20:5(5Z,8Z,11Z,14Z,17Z)) Formula: C41H63O8P (714.426) Adducts: [M+H]+ (Ppm: 2.1) |
Homo sapiens (Liver) |
20171107_FIT4_DHBpos_p70_s50Resolution: 50μm, 70x70
|
|
Cyclopassifloside VII Formula: C37H62O13 (714.419) Adducts: [M+H]+ (Ppm: 8.3) |
Mus musculus (Lung) |
image5Resolution: 40μm, 163x183
Supplementary Figure S8. MALDI-MSI data of mouse lung tissue administered with D9-choline and
U 13C-DPPC–containing Poractant alfa surfactant (labels administered 18 h prior to sacrifice). Ion
images of (a) m/z 796.6856 ([U13C-DPPC+Na]+), (b) m/z 756.5154 [PC32:0+Na]+ and (c) m/z 765.6079
([D9-PC32:0+Na]+). (d) Overlay image of [U13C-DPPC+Na]+ (red) and [D9-PC32:0+Na]+ (green).
Parts per million (ppm) mass errors are indicated in parentheses. All images were visualised using totalion-current normalisation and using hotspot removal (high quantile = 99%). DPPC = PC16:0/16:0. |
|